Nest Genomics offers an end-to-end, EMR-integrated platform that incorporates genomics into clinical workflows, including clinical decision support and patient engagement tools. The lab-agnostic, turnkey solution supports hereditary cancers, cardiovascular genetics, and conditions on the ACMG secondary findings list. Nest has launched in several large health systems and enables providers to create care plans based on clinical guidelines and patient data. The founders, Moran Snir and Guy Snir, previously built Clear Genetics (acquired by Invitae in 2019) and aim to increase access to genetic services. Nest plans to expand integrations with more EMRs, broaden clinical specialty coverage (including Pediatrics, polygenic risk scores, and pharmacogenetics), and automate additional parts of the genetic testing process. The company recently closed a Seed financing to fund customer launches, EMR integrations, and product expansion.

Total raised

$9M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2023